---
title: "Assembly生物科技 (ASMB.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/ASMB.US/norm.md"
symbol: "ASMB.US"
name: "Assembly生物科技"
parent: "https://longbridge.com/zh-CN/quote/ASMB.US.md"
datetime: "2026-05-21T22:50:36.695Z"
locales:
  - [en](https://longbridge.com/en/quote/ASMB.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ASMB.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ASMB.US/norm.md)
---

# Assembly生物科技 (ASMB.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.5400 | 1.30 | -0.7249 | -1.33 | -1.17 |
| ROE | -17.92% | 45.38% | -36.64% | -180.36% | -116.62% |
| 营业收入 | 8.21M | 42.47M | 10.79M | 9.63M | 9.42M |
| 净利润 | -9.08M | 22.09M | -9.20M | -10.20M | -8.82M |
| 营业利润 | -11.37M | 19.80M | -10.88M | -11.09M | -9.94M |
| 毛利率 | 100.00% | 59.38% | -53.74% | -67.52% | -57.67% |
| 净利率 | -110.54% | 52.01% | -85.23% | -105.94% | -93.62% |
| 利润含金量 | - | 139.07% | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 235.51M | 257.59M | 240.00M | 80.78M | 99.02M |
| 权益乘数 | 1.19 | 1.25 | 1.31 | 4.46 | 3.65 |
| 每股净资产 | 12.50 | 13.04 | 11.55 | 2.36 | 3.56 |
| 资产周转率 | 0.4251 | 0.3838 | 0.2186 | 0.3391 | 0.2938 |
| 现金及短投 | 226.60M | 248.11M | 232.56M | 74.98M | 91.03M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 2.58M | 2.73M | 2.87M | 3.00M | 3.18M |
| 净债务 | -224.11M | -245.48M | -229.80M | -72.10M | -88.01M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | - | 14.24M | -15.13M | -16.76M | -23.44M |
| 投资现金流 | - | 21.22M | -158.27M | 16.99M | 6.59M |
| 融资现金流 | - | 456000.00 | 171.93M | 357000.00 | 1.92M |
| 自由现金流 | - | 7.03M | -835875.00 | -3.40M | -7.78M |
| 现金流充裕率 | - | 59320.83% | -36030.95% | - | - |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | -24000.00 | -42000.00 | - | - |